Sex differences in the expression of the endocannabinoid system within V1M cortex and PAG of Sprague Dawley rats
Name:
s13293-021-00402-2.pdf
Size:
2.997Mb
Format:
PDF
Description:
Final Published Version
Author
Levine, A.Liktor-Busa, E.
Lipinski, A.A.
Couture, S.
Balasubramanian, S.
Aicher, S.A.
Langlais, P.R.
Vanderah, T.W.
Largent-Milnes, T.M.
Affiliation
Department of Pharmacology, University of ArizonaEndocrinology Division, Department of Medicine, University of Arizona
Endocrinology Division, Department of Medicine, University of Arizona
Issue Date
2021Keywords
2-ArachidonoylglycerolAnandamide
Endocannabinoids
Migraine
Pain
Periaqueductal grey
Proteomics
Sex differences
Metadata
Show full item recordPublisher
BioMed Central LtdCitation
Levine, A., Liktor-Busa, E., Lipinski, A. A., Couture, S., Balasubramanian, S., Aicher, S. A., Langlais, P. R., Vanderah, T. W., & Largent-Milnes, T. M. (2021). Sex differences in the expression of the endocannabinoid system within V1M cortex and PAG of Sprague Dawley rats. Biology of Sex Differences.Journal
Biology of Sex DifferencesRights
Copyright © The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Background: Several chronic pain disorders, such as migraine and fibromyalgia, have an increased prevalence in the female population. The underlying mechanisms of this sex-biased prevalence have yet to be thoroughly documented, but could be related to endogenous differences in neuromodulators in pain networks, including the endocannabinoid system. The cellular endocannabinoid system comprises the endogenous lipid signals 2-AG (2-arachidonoylglycerol) and AEA (anandamide); the enzymes that synthesize and degrade them; and the cannabinoid receptors. The relative prevalence of different components of the endocannabinoid system in specific brain regions may alter responses to endogenous and exogenous ligands. Methods: Brain tissue from naïve male and estrous staged female Sprague Dawley rats was harvested from V1M cortex, periaqueductal gray, trigeminal nerve, and trigeminal nucleus caudalis. Tissue was analyzed for relative levels of endocannabinoid enzymes, ligands, and receptors via mass spectrometry, unlabeled quantitative proteomic analysis, and immunohistochemistry. Results: Mass spectrometry revealed significant differences in 2-AG and AEA concentrations between males and females, as well as between female estrous cycle stages. Specifically, 2-AG concentration was lower within female PAG as compared to male PAG (*p = 0.0077); female 2-AG concentration within the PAG did not demonstrate estrous stage dependence. Immunohistochemistry followed by proteomics confirmed the prevalence of 2-AG-endocannabinoid system enzymes in the female PAG. Conclusions: Our results suggest that sex differences exist in the endocannabinoid system in two CNS regions relevant to cortical spreading depression (V1M cortex) and descending modulatory networks in pain/anxiety (PAG). These basal differences in endogenous endocannabinoid mechanisms may facilitate the development of chronic pain conditions and may also underlie sex differences in response to therapeutic intervention. © 2021, The Author(s).Note
Open access journalISSN
2042-6410Version
Final published versionae974a485f413a2113503eed53cd6c53
10.1186/s13293-021-00402-2
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License.